19 June 2013
Keywords: Meda, Zyclara, Actinic keratosis, Europe, Approval
Article | 29 August 2012
Sweden-based Meda (OMX: MEDA A) yesterday announced that the European Commission has granted marketing authorization for Zyclara (imiquimod 3.75% cream), a ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 August 2012
© 2013 thepharmaletter.com